BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8234341)

  • 1. Cloning and pharmacological characterization of a rat kappa opioid receptor.
    Meng F; Xie GX; Thompson RC; Mansour A; Goldstein A; Watson SJ; Akil H
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9954-8. PubMed ID: 8234341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
    Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of a cDNA for the rat kappa-opioid receptor.
    Minami M; Toya T; Katao Y; Maekawa K; Nakamura S; Onogi T; Kaneko S; Satoh M
    FEBS Lett; 1993 Aug; 329(3):291-5. PubMed ID: 8103466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells.
    Onoprishvili I; Andria ML; Vilim FS; Hiller JM; Simon EJ
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):129-37. PubMed ID: 10581406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP regulates the calcium transients released from IP(3)-sensitive stores by activation of rat kappa-opioid receptors expressed in CHO cells.
    Ikeda M; Nelson CS; Shinagawa H; Shinoe T; Sugiyama T; Allen CN; Grandy DK; Yoshioka T
    Cell Calcium; 2001 Jan; 29(1):39-48. PubMed ID: 11133354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.
    Xue JC; Chen C; Zhu J; Kunapuli S; DeRiel JK; Yu L; Liu-Chen LY
    J Biol Chem; 1994 Dec; 269(48):30195-9. PubMed ID: 7982926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons.
    Steiner H; Gerfen CR
    Neuroscience; 1999; 88(3):795-810. PubMed ID: 10363818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
    Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mu-, delta-, and kappa-opioid receptors in a human neuroblastoma cell line.
    Baumhaker Y; Wollman Y; Goldstein MN; Sarne Y
    Life Sci; 1993; 52(19):PL205-10. PubMed ID: 8387137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.
    Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G
    J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and distribution of a cloned rat mu-opioid receptor.
    Bunzow JR; Zhang G; Bouvier C; Saez C; Ronnekleiv OK; Kelly MJ; Grandy DK
    J Neurochem; 1995 Jan; 64(1):14-24. PubMed ID: 7798908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.
    Stiene-Martin A; Zhou R; Hauser KF
    Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.